Sunday Sep 05

Defective drug Seroquel lawsuits already involve millions of dollars

seroquel-pic3.jpgJust last October, 2009, Seroquel manufacturer AstraZeneca indicated it reached a $520 million agreement for settling two "whistle-blower" lawsuits as well as two federal investigations over its marketing and selling of defective drug Seroquel.

Among the two federal investigations, one concerned selected physicians who'd been part of Seroquel clinical trials, while the other involved off-label promotion of the drug, whose off-label uses can include treating insomnia and anxiety disorders.
Such off-label uses, spurred by intense marketing measures from AstraZeneca, have led to Seroquel being prescribed increasingly for elderly persons and for children. Though doctors can prescribe any approved drugs for an off-label use, in Seroquel's case this has been done for health conditions for which the Food and Drug Administration has not approved its use.

Multiple lawsuits launched against Seroquel

Company spokesperson Tony Jewell did not indicate the names of the physicians or the nature of the clinical trials which have been investigated. Also, the names of the whistle-blowers are sealed in federal court. But Jewell did say that AstraZeneca was finalizing its settlements of the whistle-blower lawsuits and would reach a corporate integrity agreement with the U.S. Department of Justice.

Seroquel's lawsuit history continues to grow. Individuals also have filed Seroquel defective drug lawsuits against AstraZeneca in the United States, asserting personal injury and product liability. Also, at least four class-action suits have been filed against the defective drug's manufacturer in Canada.

If you or a loved one has suffered harm due to defective drug Seroquel, you also may be entitled to seek financial recovery via a Seroquel lawsuit. Notify Attorney Robert Goldwater by contacting the Bob Goldwater Law Firm, and begin the process of gaining that recovery.